{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-033458","form_type":"8-K","ticker":"KYNB","cik":"0000921299","company_name":"KYNTRA BIO, INC.","filed_at":"2023-07-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:37.036247+00:00","generated_at":"2026-06-13T06:46:20.247585+00:00","sec_items":["2.05"],"event_type":"other_material","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"FibroGen cuts US workforce 32% (104 employees); expects $13-15M charges","bullets":["Workforce reduction of ~32% (104 U.S. employees) approved July 14, 2023.","Non-recurring charges of $13-15M for severance, notice pay, vacation, benefits.","Plan expected to generate $30-35M in annual cost savings.","Majority of charges in Q3 2023; reduction substantially complete by Q1 2024.","Company expects existing cash, equivalents, investments to fund ops into 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-033458","json":"https://secwatch.observer/filing/0000950170-23-033458.json","markdown":"https://secwatch.observer/filing/0000950170-23-033458.md","text":"https://secwatch.observer/filing/0000950170-23-033458.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/921299/000095017023033458/0000950170-23-033458-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/921299/000095017023033458/fgen-20230714.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T06:46:20.247585+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8fd10b0941ad9575c67232c5120ec39b998d639f","claim":"KYNTRA BIO, INC. announced a restructuring with charges of $13-15 million affecting U.S. workforce (approximately 32% (or 104 employees)).","evidence_excerpt":"The Company estimates that it will incur non-recurring charges in the range of $13-15 million in connection with the Plan, primarily consisting of severance payments, notice pay, accrued vacation, and employee benefits contributions.","evidence_source":"SEC 8-K Item 2.05/2.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/921299/000095017023033458/0000950170-23-033458-index.htm","confidence":0.9,"family_label":"Restructurings & Charges","details":[{"label":"Type","value":"restructuring"},{"label":"Charge","value":"$13-15 million"},{"label":"Affected area","value":"U.S. workforce"},{"label":"Headcount","value":"approximately 32% (or 104 employees)"}],"fact_type":"restructuring_charge"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}